BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30372820)

  • 1. Gene therapy and type 1 diabetes mellitus.
    Chellappan DK; Sivam NS; Teoh KX; Leong WP; Fui TZ; Chooi K; Khoo N; Yi FJ; Chellian J; Cheng LL; Dahiya R; Gupta G; Singhvi G; Nammi S; Hansbro PM; Dua K
    Biomed Pharmacother; 2018 Dec; 108():1188-1200. PubMed ID: 30372820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene and cell therapies for diabetes mellitus: strategies and clinical potential.
    Giannoukakis N; Robbins PD
    BioDrugs; 2002; 16(3):149-73. PubMed ID: 12102644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of adipose-derived stem cells in type 1 diabetes mellitus.
    Lin HP; Chan TM; Fu RH; Chuu CP; Chiu SC; Tseng YH; Liu SP; Lai KC; Shih MC; Lin ZS; Chen HS; Yeh DC; Lin SZ
    Cell Transplant; 2015; 24(3):521-32. PubMed ID: 25621468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
    Casu A; Trucco M; Pietropaolo M
    Pediatr Clin North Am; 2005 Dec; 52(6):1779-804. PubMed ID: 16301093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes type 1: Can it be treated as an autoimmune disorder?
    Vallianou NG; Stratigou T; Geladari E; Tessier CM; Mantzoros CS; Dalamaga M
    Rev Endocr Metab Disord; 2021 Dec; 22(4):859-876. PubMed ID: 33730229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
    Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M
    Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cell Therapy and Type 1 Diabetes Mellitus: Treatment Strategies and Future Perspectives.
    Farooq T; Rehman K; Hameed A; Akash MSH
    Adv Exp Med Biol; 2019; 1084():95-107. PubMed ID: 29896720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet Microencapsulation: Strategies and Clinical Status in Diabetes.
    Omami M; McGarrigle JJ; Reedy M; Isa D; Ghani S; Marchese E; Bochenek MA; Longi M; Xing Y; Joshi I; Wang Y; Oberholzer J
    Curr Diab Rep; 2017 Jul; 17(7):47. PubMed ID: 28523592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
    Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
    J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons on autoimmune diabetes from animal models.
    Yang Y; Santamaria P
    Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.
    Yi B; Huang G; Zhou ZG
    Chin Med J (Engl); 2015 Sep; 128(17):2387-94. PubMed ID: 26315089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
    Vanikar AV; Trivedi HL; Thakkar UG
    Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Original hypothesis: Extracorporeal shockwaves as a homeostatic autoimmune restorative treatment (HART) for Type 1 diabetes mellitus.
    Craig K; d'Agostino C; Poratt D; Walker M
    Med Hypotheses; 2014 Sep; 83(3):250-3. PubMed ID: 24947195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus.
    Hou WR; Xie SN; Wang HJ; Su YY; Lu JL; Li LL; Zhang SS; Xiang M
    Pharmacol Res; 2011 Apr; 63(4):320-7. PubMed ID: 21185938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
    Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in immunotherapy of type I diabetes.
    Ni Q; Pham NB; Meng WS; Zhu G; Chen X
    Adv Drug Deliv Rev; 2019 Jan; 139():83-91. PubMed ID: 30528629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide gene expression profiling reveals that CD274 is up-regulated new-onset type 1 diabetes mellitus.
    Fang C; Huang Y; Pei Y; Zhang HH; Chen X; Guo H; Li S; Ji X; Hu J
    Acta Diabetol; 2017 Aug; 54(8):757-767. PubMed ID: 28577136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral infections in type 1 diabetes mellitus--why the β cells?
    Op de Beeck A; Eizirik DL
    Nat Rev Endocrinol; 2016 May; 12(5):263-273. PubMed ID: 27020257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and primary prevention trials for type 1 diabetes.
    Wu YL; Ding YP; Gao J; Tanaka Y; Zhang W
    Int J Biol Sci; 2013; 9(7):666-79. PubMed ID: 23904791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.